# A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

> **NCT07137689** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 32 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** LY3537982

## Key facts

- **NCT ID:** NCT07137689
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-18
- **Primary completion:** 2026-04-10
- **Final completion:** 2026-04-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07137689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07137689, "A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07137689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*